Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03717753 · ClinicalTrials.gov registry record · NA

Rotator Cuff Pathway

A NA study of Shoulder Pain, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT03717753 is a NA study of Shoulder Pain that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 140 participants, above the 96-participant average among 27 other Shoulder Pain trials with a reported enrollment target (46% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03717753, a NA study of Shoulder Pain, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

Rotator cuff surgery is mostly performed on an outpatient basis, and many patients still experience moderate to severe pain after surgery, despite the use of regional anesthesia and opioids. The specific aim is to determine whether a comprehensive pathway that includes a well-defined regional technique and multimodal analgesia will reduce the worst pain with movement 0-48 hours after block placement compared to the current standard practice. This is a 'before and after' study. We plan to have 70 patients studied prior to initiation of a pathway, and 70 patients studied after initiation of a pathway. Both groups will receive identical postoperative follow-up.

Conditions Studied

Interventions

  • OTHER Pathway

Study Locations (1)

New York

  • Hospital of Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2018-09-07
Est. Completion 2020-03-01
Phase NA

What the Registry Record Tells You About NCT03717753

The ClinicalTrials.gov registry entry for NCT03717753 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 96-participant average among 27 other Shoulder Pain trials with a reported enrollment target (46% higher). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Shoulder Pain appearing as the primary indexed condition, and to 1 intervention - of which Pathway is the first listed.

NCT03717753 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03717753 about?

NCT03717753 is a clinical study titled "Rotator Cuff Pathway". Rotator cuff surgery is mostly performed on an outpatient basis, and many patients still experience moderate to severe pain after surgery, despite the use of regional anesthesia and opioids. The specific aim is to determine whether a comprehensive pathway that includes a well-defined regional techni...

What is the current status of trial NCT03717753?

This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2018-09-07. Estimated completion is 2020-03-01.

What conditions does trial NCT03717753 study?

This clinical trial studies the following conditions: Shoulder Pain.

What interventions are being tested in trial NCT03717753?

The interventions under investigation include: Pathway (OTHER).

Who is sponsoring clinical trial NCT03717753?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03717753 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.